Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Eugia Pharma Speclts Drug Patent Portfolio

Eugia Pharma Speclts owns 1 orange book drug protected by 1 US patent Given below is the list of Eugia Pharma Speclts's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9662342 Formulations of cyclophosphamide liquid concentrate 26 Jun, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of Eugia Pharma Speclts.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 30 May, 2024 US10849916
Payment of Maintenance Fee, 4th Yr, Small Entity 08 May, 2024 US10993952 (Litigated)
Recordation of Patent Grant Mailed
Critical
12 Jul, 2022 US11382923
Patent Issue Date Used in PTA Calculation
Critical
12 Jul, 2022 US11382923
Email Notification
Critical
23 Jun, 2022 US11382923
Issue Notification Mailed
Critical
22 Jun, 2022 US11382923
Dispatch to FDC 08 Jun, 2022 US11382923
Application Is Considered Ready for Issue
Critical
08 Jun, 2022 US11382923
Issue Fee Payment Received
Critical
06 Jun, 2022 US11382923
Issue Fee Payment Verified
Critical
06 Jun, 2022 US11382923
Letter Accepting Correction of Inventorship Under Rule 1.48 06 May, 2022 US11382923
Email Notification
Critical
06 May, 2022 US11382923
Filing Receipt - Updated 06 May, 2022 US11382923
Miscellaneous Incoming Letter 03 May, 2022 US11382923
Email Notification
Critical
25 Apr, 2022 US11382923


Eugia Pharma Speclts's Family Patents

Eugia Pharma Speclts drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 38.5% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Eugia Pharma Speclts Drug List

Given below is the complete list of Eugia Pharma Speclts's drugs and the patents protecting them.


1. Cyclophosphamide

Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9662342 Formulations of cyclophosphamide liquid concentrate 26 Jun, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List